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ABSTRACT  TO identify platelet surface structures involved in adhesion to collagen, the effect 
of 16 murine antiplatelet membrane hybridoma antibodies were tested in a defined, in vitro 
assay.  Four  of  these  antibodies  inhibited  platelet-collagen  adhesion  and  reacted  with  a 
polypeptide  with  Mr  ~  125,000,  as determined  by  immunoblots  after  gel  electrophoresis 
under  reducing  conditions.  Through  detailed  studies  with  one  of  these  antibodies,  the 
monoclonal antibody PMI-1, the relevant antigen was identified as platelet glycoprotein Ilba, 
based upon (a) co-migration with this glycoprotein in two-dimensional gel electrophoresis and 
(b) co-purification by immunoaffinity chromatography with a protein with apparent Mr identical 
to that of glycoprotein III, under conditions in which glycoproteins lib and III form a complex. 
Univalent antibody fragments  prepared from  monoclonal antibody PMI-1 inhibited >80% 
of platelet-collagen adhesion, and inhibition was completely blocked by the immunopurified 
antigen. These results  indicate that glycoprotein  lib participates  in some aspect of platelet- 
collagen  adhesion.  In  contrast,  the  purified  antigen  only  partially  neutralized  a  polyclonal 
antiserum  that  blocked  platelet-collagen  adhesion, to  a  maximum  of  ~25%,  at  saturating 
antigen concentrations. Thus, by these immunological criteria, glycoprotein lib is not the only 
molecule involved in this process. 
Antibodies are a  major tool for identification of molecules 
that participate in cell adhesion. Iterative absorption of poly- 
clonal antibodies has permitted identification of several cell 
adhesion molecules (1). An additional approach has employed 
monoclonal antibodies, which offer  the advantage of  exquisite 
immunologic specificity.  These have been  used to identify 
molecules involved in  the  adhesion  of myoblasts (2)  and 
melanoma cells (3) to surfaces in tissue culture, and of Dic- 
tyostelium discoideum cells to each other (4). 
In the  preceding article, we described a  polyclonal anti- 
serum raised against whole human blood platelets that was 
employed to identify and partially purify neutralizing antigens 
involved in  platelet-collagen adhesion (5).  This work was, 
however, greatly complicated by the finding that the adhesion 
that was measured in this assay apparently involved several 
immunologically distinct molecular entities, each of which 
only partially neutralized the polyclonal antiserum. Because 
of the complexities of the system, we turned to monoclonal 
antibodies to develop monospecific reagents that might react 
with the relevant entities individually, permitting their clear 
identification and independent characterization. We describe 
here a monoclonal antibody that reacts specifically with plate- 
let membrane glycoprotein IIb and blocks platelet-collagen 
adhesion.  The platelet antigen  purified by immunoaffinity 
chromatography, using immobilized monoclonal antibody, 
only partly neutralizes the polyclonal antiserum described in 
the preceding article (5), supporting the conclusion that mul- 
tiple entities are involved in platelet-collagen adhesion. 
MATERIALS  AND  METHODS 
Hybridoma Production:  Balb C  mice were  immunized  biweekly 
with 50/~g of platelet membranes (6), emulsified alternately in complete and 
incomplete Freund's adjuvant. After four immunizations,  mice were bled from 
the  retroorbital  plexus,  and  sera  were  screened  for antiplatelet  membrane 
antibodies utilizing a solid-phase radioimmunoassay  (see below). The animals 
showing  the  highest  titers  were  boosted  with  300  ~g  platelet  membranes 
intravenously 6, 3, and 1 d before sacrifice. Mice were killed, and washed spleen 
cell suspensions  containing  1.5  x  l08  cells/ml  fused  with  P3X63-AgS.653 
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ene glycol-  1000 for 7 min as described (7). The fused cells were grown in HAT 
medium (7)  for 3 d  before  being  distributed  in  32  microtiter  plates,  each 
containing 96 wells. 
Growing single colonies of cells were screened in the radioimmunoassay, 
and 58 culture supernatants,  which gave signals greater than twice background, 
were cloned by limiting dilution  at a density of 0.5 cells per well. 21  d alter 
subcloning,  position  subclones were selected utilizing the radioimmunoassay 
on culture supernatants.  16 of these were subsequently expanded and frozen in 
liquid  nitrogen  with  cryoprotection.  In addition,  positive subelones  of well 
4D6, which secreted the monoclonal antibody designated PMI-1, were recloned 
on two separate occasions, then expanded, and 5 x  107 cells/mouse  injected 
intraperitoneally  into pristane-primed  mice (8). Ascites fluid developed within 
l  wk  of injection  and  was harvested  and  stored  at  -70*.  Ascites from all 
subclones exhibited a single band in the 3' region on cellulose acetate electro- 
phoresis. 
Radioimmunoassay:  Polyvinyl  chloride  microtiter  plates  (#3911, 
Falcon Plastics, Oxnard,  CA) were coated with 5 pg/well platelet membranes 
in phosphate-buffered saline at 4* for 24-72 h. After washing and blocking with 
2% bovine  serum albumin,  the plates were exposed to culture  supernatants, 
ascites or sera for 3 h at 22*, washed in phosphate-buffered  saline containing 
0.05%  Tween 20 and 0.1% bovine  serum albumin, and developed  utilizing 
affinity-purified goat anti-mouse  IgG radioiodinated  to a specific activity of 2- 
5 uCi/pg by the chloramine-T  technique (8). After washing the wells were cut 
out with a hot wire and counted  in a 3' counter.  Positive controls  contained 
serum from mice immunized with platelet membranes,  and negative controls 
contained normal mouse serum, culture medium, and medium from the parent 
myeloma line. 
Preparation of Fab from Clone PMI-1:  IgO was prepared  from 
the ascites fluid of clone PMI-I by affinity chromatography  on a column of 
protein  A-agarose  (Pharmacia  Fine  Chemicals,  Piscataway,  NJ)  in  0.1  M 
sodium phosphate  buffer, pH 8.0. Fab was prepared by digestion with papain 
as described  previously (5) and Fc fragments  were removed  by rechromato- 
graphing the solution  on protein  A-agarose.  Fabs were tested  for purity  by 
PAGE in SDS under nonreducing  conditions  (9). They  were also tested for 
reactivity with goat anti-mouse Fab (Cappel Laboratories, Philadelphia, PA) by 
immunodiffusion. 
PAGE and  Immunoblotting:  PAGE  in slab gels under standard 
reducing conditions  was performed  as described  by Laemmli  (9) using pre- 
stained protein standards (Bethesda Research Laboratories, Rockville, MD) as 
measures of apparent molecular  weights. Proteins  were located with a silver 
stain (10). lmmunohlots of proteins electrophoretically transferred to nitrocel- 
lulose paper were performed as described previously (4). Antibodies bound to 
the antigens on the nitrocellulose transfers were visualized by incubation  with 
goat anti-mouse  peroxidase conjugated  IgG (Cappel Laboratories) followed by 
development  in 0.16 mg/ml 4-o-chloronaphthol  containing  0.3% H202, as 
described previously (4). 
Two-dimensional gel electrophoresis under reducing and nonreducing con- 
ditions was performed in 7.5 % acrylamide gels by the technique of Phillips and 
Agin ( l l). In these experiments, the platelet membrane proteins were iodinated 
by the lactoperoxidase catalyzed iodination  technique (1 l) as described (12). 
Immunoaffinity Chromatography:  5 mgofmonoclonal antibody 
PMI-1 was dialyzed against 0.1  M bicarbonate  buffer, pH 8.0, and coupled to 
2 ml of cyanogen bromide-activated  Sepharose~(Pharmacia Fine Chemicals) as 
described by the manufacturer.  After coupling, active groups were blocked by 
incubation  in 0.1 M ethanolamine,  pH 9.0, and the gel was extensively washed. 
Immunoaffinity chromatography  was performed essentially as described by 
McEver et al. (l 3). Detergent extracts of outdated platelets were prepared using 
1% octylglucoside or 1% Triton X-100 as described (5). Samples were dialyzed 
against Tris saline (15 mN Tris-HC1, pH 7.4, 126 mM NaC1, 5.4 mM KCI, 5 
x  10  -3 M CaC12, 1 mM MgCl2, 0.1% glucose) to reduce detergent concentration, 
applied to the column, and recirculated through the column for 24 h at 4"C to 
maximize specific binding.  Washing of the column was done by successively 
eluting with: 0.15 M NaCl, 20 mM Tris-HCl, pH 7.4; 1 M NaCl, 20 mM Tris- 
HCI, pH 7.4; 0.1  M Na borate,  pH 8.0. All buffers contained  0.1% octylglu- 
coside. Bound platelet protein  was then eluted using 0.2 M diethylamine,  pH 
11.5. The eluate was immediately  neutralized with l M Tris-HCl, pH 6.8, and 
dialyzed against Tris saline. 
Platelet-Collagen  Adhesion  Assay:  This was performed  as de- 
scribed previously (5,  14). Screening the effects of tissue culture  supernatants 
from hybridoma  clones was done by preincubating  5JCr-labeled platelets with 
dilutions of the supernatants that had been heat inactivated at 56"C for 20 min, 
then measuring  platelet-collagen  adhesion  in the normal way. Measurement 
of  the effects of Fab prepared from monoclonal antibodies on platelet-coUagen 
adhesion,  and neutralizing  effects of various antigens was done as described 
previously (5). 
RESULTS 
In  a  search  for  monoclonal antibodies  that  block  specific 
molecules involved in platelet-collagen adhesion, we screened 
a series of antiplatelet membrane hybridoma supernatants as 
inhibitors of our adhesion assay. For these initial experiments, 
we used intact immunoglobulins in culture medium, to ob- 
viate the need to prepare univalent antibody fragments. Many 
of these antibodies agglutinated the platelets at high concen- 
trations and were, therefore, screened at the highest concen- 
trations that did  not cause agglutination.  Of 16  hybridoma 
supernatants screened in this assay, four had significant effects 
on platelet-collagen adhesion, inhibiting at least 20%, whereas 
the  others  had  no  apparent  effect.  All  four  of the  active 
hybridoma supernatants reacted with a protein band of Mr ~ 
125,000  in  whole-platelet extracts,  when  examined  by  the 
nitrocellulose-transfer technique (Fig.  1, a-d). In contrast, a 
hybridoma supernatant that did not block platelet-collagen 
adhesion reacted with several other bands (Fig.  1 e).  Super- 
natants from the parent cell line used to make the hybridomas, 
or from a cell line making an unrelated monoclonal antibody 
did not bind platelet proteins (Fig.  1, fand g). 
We selected one of the adhesion-blocking cell lines, PMI-1 
for further experiments. It was recloned by limiting dilution 
and injected into a mouse peritoneum. The resultant ascites 
fluid contained an IgG~k antibody that was homogeneous by 
cellulose acetate electrophoresis. To obviate effects of the Fc 
region or bivalency,  Fab  fragments were prepared from the 
purified  antibody.  The  Fab  fragments  inhibited  -50%  of 
platelet-collagen adhesion at 20 pg/ml,  and inhibited >80% 
of adhesion at higher concentrations (Fig. 2). In contrast, Fab 
fragments  prepared  from  another  monoclonal  antibody, 
FIGURE  1  Immunoblotting of whole-platelet extract with five hy- 
bridoma supernatants  that  bind  platelet surface  antigens.  Tissue 
culture supernatants of antiplatelet hybridoma clones were diluted 
1:4, incubated with a nitrocellulose blot of a 7.5% SDS polyacryl- 
amide slab gel of whole human platelets, and developed using goat 
anti-mouse peroxidase  conjugate.  Supernatants were derived from 
the following: (lane a) clone 23B7;  (lane b) clone 25B5;  (lane c) 
clone  PMI-1;  (lane  d)  clone  6D2;  (lane  e)  clone 23E7; (lane  f) 
myeloma MP-8  ascites fluid;  and  (lane  g)  a  clone  producing a 
monoclonal antibody directed against ferritin.  Bars represent  the 
positions of prestained molecular weight standards with apparent 
M, ~ 200,000, 93,000, 68,000, and 43,000. The arrow indicates the 
migration of a protein with apparent M, ~  125,000. 
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glycoprotein III, had no effect on platelet-collagen adhesion 
at up to 240 ~g/ml (Fig. 2). 
In  that  antibody  PMI-I  reacted  with  a  unique  platelet 
antigen, we covalently linked it to a solid support and used it 
to purify the relevant antigen by immunoaffinity chromatog- 
raphy. With this procedure, we obtained a  preparation en- 
riched in a major protein band with Mr ~  125,000 as well as 
a fainter band with Mr -  100,000 upon PAGE in SDS under 
reducing conditions (Fig. 3). These bands had mobilities like 
those of glycoproteins IIb and III. Since the antibody bound 
only to the band with Mr ~  125,000, it seemed likely that we 
had immunopurified the glycoprotein lib/Ill complex, as had 
others (13,  15, 16) with other monoclonal antibodies. 
To  further  analyze  antibody  specificity,  membranes  of 
platelets that had been surface labeled with ~25I  were separated 
by two-dimensional  electrophoresis and  electrophoretically 
transferred to  nitrocellulose paper.  The  separated  proteins 
were then analyzed by immunoblotting with PMI-I, which 
was developed with an immunoperoxidase procedure and by 
autoradiography to  determine the  location  of the  platelet 
surface proteins that had incorporated '2~I. PMI-1 bound to a 
single spot of apparent Mr ~  133,000 nonreduced, -  123,000 
reduced, confirming its monospecificity (Fig.  4).  This spot 
exactly coincided with a spot heavily labeled with '2~I that ran 
beneath the diagonal (Fig. 4). It is identified as the glycopro- 
tein Ilba band, because of its mobility in this gel system and 
the intensity of labeling. 
The antigen, immunopurified on a PMI-1 column, reacted 
well  in  immunoblots  not  only with  monoclonal antibody 
PMI-1  (Fig.  5,  lane  g)  but  also  with  a  partially  purified 
antiplatelet antibody preparation (Fig. 5, lane b) that blocked 
platelet-collagen adhesion (5). The same protein was appar- 
ently present in the "enriched neutralizing antigens" prepa- 
ration  (Fig.  5,  lanes  e  and f)  that  partially  inhibited  the 
adhesion-blocking activity of the polyclonal antiserum (5). It 
was also prominent in the detergent phase of a  1% Triton X- 
114 partition of an extract of whole-platelet membranes (Fig. 
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Fab  CONCENTRATION, /,~g/ml 
Effects  on platelet-collagen adhesion of Fabs of mono- 
clonal antibodies PMI-1  (0) and 22C4 (O). The Fabs were prepared 
from ascites fluid  dialyzed into modified. Tyrode's  buffer,  pH  7.4, 
and  tested  in  the  platelet-collagen  adhesion  assay.  Fabs  were 
preincubated with SlCr-labeled platelets in assay buffer for 10 rain 
at 370C, and platelet-collagen adhesion was assayed as described 
in Materials and Methods. 
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FIGURE  3  PAGE  of  platelet proteins  purified 
from a crude octylglucoside extract by binding 
to  a  column  containing  immobilized  mono- 
clonal antibody PMI-1. Proteins were visualized 
with  a silver stain. The  upper arrow indicates 
the migration of glycoprotein lib, and the lower 
migration  of  a  glycoprotein  Ilia,  electropho- 
resed in parallel. 
5, lane h), indicating that it is hydrophobic and appears to be 
an integral membrane protein (17). 
The protein with Mr -  125,000  is apparently highly anti- 
genic.  This is suggested  not only by the ease of detection of 
multiple monoclonal antibodies that apparently react with it 
(Fig.  l) but also by the abundance of antibodies that react 
with it in  a  polyclonal antiserum. This is indicated by the 
strong reaction of a  partially purified polyclonal antiserum 
(5) with a band with Mr -  125,000 in a crude platelet extract 
(Fig. 5, lane a). Furthermore, it is the only prominent protein 
band  in  enriched neutralizing antigens  (5)  that  binds  this 
partially purified antiserum (Fig. 5, lane c). 
Because the proteins purified on the monoclonal antibody 
column reacted with the adsorbed polyclonal antibody on 
immunoblots, we sought to determine whether they neutral- 
ized  the  rabbit  antibody  in  adhesion  assays.  The  protein 
preparation that was purified on the immobilized monoclonal 
antibody column  neutralized up  to  ~20%  of the platelet- 
collagen adhesion-blocking activity of  the polyclonal Fab (Fig. 
6), under standard assay conditions in which the polyclonal 
Fab inhibited 50%  of platelet-collagen adhesion. This result 
was consistently observed in a  number of experiments, and 
in no case was inhibition greater than 25%. In contrast, the 
enriched neutralizing antigens prepared in the previous report 
neutralized the polyclonal Fab by a maximum of-60% (Fig. 
6). These results indicate that antibodies against a mixture of 
glycoproteins IIb  and  III  account  for only  a  part  of the 
adhesion-blocking activity of  the polyclonal antibody. In con- 
trast,  the  immunopurified glycoproteins IIb  and  III  com- 
pletely neutralized the  inhibitory activity of Fab  prepared 
from PMI-1  (Fig. 7). 
DISCUSSION 
These experiments underscore the power of  using monoclonal 
antibodies to screen for cell adhesion molecules and support FIGURE 4  Co-migration  of 
the  antigen  that  reacts with 
monoclonal  antibody  PMI-1 
and the cz-subunit  of glycopro- 
tein  lib,  on  two-dimensional 
PAGE.  Electrophoresis  was 
done under nonreducing con- 
ditions in one dimension and 
under reducing conditions in 
the  other.  The  a-subunit  of 
glycoprotein  lib  is  indicated 
by the arrows on the autora- 
diogram  of  platelet  mem- 
brane proteins that had been 
radioiodinated by  surface  la- 
beling. The antigen that binds 
monoclonal antibody PMI-1 is 
visualized on a  nitrocellulose 
transfer by an immunoperoxi- 
dase  procedure,  designated 
Western  blot. 
FIGURE 5  Immunoblots with  polyclonal immunoglobulins (lanes 
a-d) and monoclonal antibody PMI-I  (lanes e-h). Whole platelets 
and various purified preparations were electrophoresed and trans- 
ferred to nitrocellulose sheets as described in Materials and Meth- 
ods. Lanes  a-c were reacted with a partially purified polyclonal  anti- 
platelet immunoglobulin preparation, which  had  been adsorbed 
with the components of an octylglucoside extract of platelets that 
did not bind to immobilized wheat germ agglutinin (5). Lane d was 
reacted with preimmune rabbit antiserum.  Lanes e-h were reacted 
with  monoclonal antibody  PMI-I  purified  from  ascites fluid  by 
affinity chromatography  on protein A-Sepharose.  The antigen prep- 
arations used were the following: (lanes a, d, and e) whole platelets; 
(lanes b and g) protein purified by immunoadsorption on a column 
of monoclonal  antibody PMI-I ; (lanes c and f) enriched neutralizing 
antigens  (5); and  (lane  h)  detergent phase  of  I%  Triton  X-114 
partition of an extract of whole platelet membranes.  Bound anti- 
bodies were visualized by the peroxidase procedure, as described 
in Materials and Methods. 
previous findings  in  other systems that  such  monospecific 
agents can completely block adhesion (2-4). They also indi- 
cate that glycoprotein lib participates directly or indirectly in 
some aspect of the platelet-collagen adhesion process. 
The best evidence that the target for monoclonal antibody 
PMI- 1 is glycoprotein lib comes from studies of its migration 
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EXTRACT  PROTEIN  CONCENTRATION t  ,ug/ml 
Comparative neutralization of antiplatelet Fab by anti- 
gens purified on a PMI-1 column, and enriched neutraliiing  antigens 
(5). The antiplatelet Fab was added at a concentration  that inhibited 
50% of platelet-collagen  adhesion. Neutralizing  activity of enriched 
neutralizing antigens (5) (O), and antigen eluted from a column of 
monoclonal antibody PMI-1 (O) were tested at the concentrations 
indicated. Results are mean _SE of triplicate determinations. 
FIGURE 7  Neutralization 
of monoclonal Fab PMI-I  ~  100 
by antigen affinity-purified  ~  80 
on immobilized PMI-I. Fab  -=, 
concentration  was  ad-  ~  60 
justed to yield -50% inhi-  _~ 
bition of platelet-collagen  ~  40 
adhesion,  and  neutraliza-  <  l-- 
tion by the indicated con-  ~  20 
centrations  of antigen was 
determined.  0 
~  80 
0.5  1.0  1.5 
PMI-1 ANTIGEN  ADDED  (#g/ml) 
in two-dimensional PAGE under reducing and nonreducing 
conditions. After resolving platelet constituents in this way, 
only one spot reacts with the  monoclonal antibody and  it 
migrates exactly with a radioiodinated spot with the mobility 
of glycoprotein Ilba. Further support for this identification 
comes from the finding that, upon affinity chromatography 
on the column of immobilized monoclonal antibody PMI-1, 
the antigen that binds this antibody co-purifies with another 
platelet protein that migrates like glycoprotein III on reduced 
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clonal antibodies directed against glycoprotein lib (13),  pre- 
sumably because these two glycoproteins associate with each 
other in detergent extracts of the platelet plasma membrane 
(13,  15). 
In most previous work, glycoprotein lib has been implicated 
in platelet aggregation and  fibrinogen binding (18-20),  but 
not  in  platelet adhesion  (21).  Because  our assay measures 
adhesion rather than aggregation, we conclude that glycopro- 
tein lib or a sterically related structure is also involved in this 
platelet function.  The finding that glycoprotein lib and  III 
may become physically associated with the cytoskeleton (22) 
and might thereby mediate the spreading and shape change 
of platelet could explain its participation  in  both adhesion 
and aggregation. Based on binding studies with Lens culinaris 
agglutinin and collagen, Tsunehisa et al. have also concluded 
that glycoprotein lib participates in platelet-collagen adhesion 
(23). 
The present studies provide strong support for the inference, 
based on polyclonal antibody studies, that platelet-collagen 
adhesion  involves more than  one immunologically distinct 
entity. Using the monoclonal antibody PMI-1, we have puri- 
fied one of these entities and found that it can neutralize no 
more than  25%  of the  platelet-collagen adhesion-blocking 
activity of a polyclonal antiplatelet antiserum. Based on rea- 
soning like that in the previous paper (5),  this suggests  that 
-25% of the active antibody in that polyclonal preparation is 
directed against glycoproteins lib and III but that additional, 
distinct components of  the antibody preparation bind to other 
relevant platelet membrane substances that are also involved 
in platelet-collagen adhesion. For the reasons given previously 
(5), these entities behave as though they are interdependent. 
It is notable that, had we begun our work with monoclonal 
antibody PMI-1, which can block platelet-collagen adhesion 
completely and be totally neutralized by glycoprotein lib, we 
might have erroneously concluded  that this glycoprotein is 
the only "platelet-collagen adhesion molecule." After all, the 
monoclonal  antibody  can  inhibit  platelet  adhesion  com- 
pletely, and the neutralizing antigen can completely neutralize 
it.  Yet, the finding that glycoprotein lib only partially neu- 
tralizes the polyclonal antiserum, and that other distinct neu- 
tralizing  fractions  have  been  identified,  invalidates  what 
would  have  been  a  reasonable  inference.  Indeed,  there  is 
evidence  (24)  that  another  platelet  molecule,  with  Mr  ~ 
65,000, may participate in platelet-collagen adhesion by bind- 
ing directly to the a chain of the collagen molecule. 
Note Added in Proof."  While  this paper was in press, Kotite (Kotite, 
N. J., J. V. Stavos, and L. W. Cunningham) reported (Biochemistry, 
1984, 23:3099-3104) that cross-linking glycoprotein lib/Ilia with a 
photoaffinity agent specifically  blocked collagen-induced platelet ag- 
gregation. This verifies our findings by an independent, nonimmu- 
nological method  and  further  implicates glycoprotein lib/Ilia  in 
platelet-collagen interactions. 
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